Wong, Founder and CEO of HCW Biologics, stated, “In the third quarter 2024, the Company expanded our product portfolio and possible disease indications that may be treated with our immunotherapeutic ...

Net income from continuing operations attributable to Consolidated Water stockholders for the third quarter of 2024 was $5.0 million or $0.31 per diluted share, compared to net income of $8.8 million ...